Thing

Test yourself: the 2023 CPD and Learning quiz

Assess your knowledge on topics ranging from infectious diseases, to professional skills, to cardiology, in our end-of-year CPD and learning quiz.…

Life cycle adjustment left out of statutory scheme on pricing of NHS medicines

The government will not apply a life cycle adjustment mechanism to levies on branded drugs sold to the NHS under the statutory scheme.…

Pharmacy has a role in innovation adoption in healthcare systems

Collaboration between integrated care systems and pharmacy teams is essential to developing innovative patient services that reduce health inequalities.…

European regulator’s committee recommends new safety measures for medicines containing pseudoephedrine

The European Medicines Agency's risk assessment committee has recommended that medicines containing pseudoephedrine should not be used in patients with severe or uncontrolled high blood pressure, or people with severe acute or chronic kidney disease or failure.…

Pharmacy negotiator warns chancellor of effect of National Living Wage on community pharmacies

Jeremy Hunt announced in the autumn statement that the National Living Wage would increase from £10.42 to £11.44 per hour from April 2024.…

Exceptional pharmacy professionals hailed in The Pharmaceutical Journal’s 2023 ‘Women to Watch’ list

The 11 women on this year’s shortlist, including students, pharmacy technicians and pharmacists, have been celebrated for making “incredible contributions” to the profession.…

PrEP highly effective in cutting HIV transmission but better access needed, study finds

Results of the 'PrEP Impact' trial show that PrEP reduced the chances of someone getting HIV by around 87%.…

New valproate prescriptions must be signed off by two specialist doctors from January 2024, says MHRA

The requirement for valproate prescriptions, which will come into effect on 31 January 2024, was first announced in December 2022.…

Putting Pharmacy First: a welcome change of policy

Pharmacy First requires careful implementation but provides an opportunity, says The Pharmaceutical Journal’s health policy columnist.…

Around 85% of patients on ADHD medication have been affected by shortages, survey indicates

A survey by ADHD UK showed that 27% of respondents received no supply of their ADHD medication, 33% had faced “long gaps” and 25% had experienced “short gaps” in the supply of their drugs.…